BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: a review

X An, AK Tiwari, Y Sun, PR Ding, CR Ashby Jr… - Leukemia research, 2010 - Elsevier
Chronic Myeloid Leukemia (CML) is a clonal disease characterized by the presence of the
Philadelphia (Ph+) chromosome and its oncogenic product, BCR-ABL, a constitutively active …

Tyrosine kinase inhibitors as modulators of ABC transporter-mediated drug resistance

S Shukla, ZS Chen, SV Ambudkar - Drug resistance updates, 2012 - Elsevier
Tyrosine kinases (TKs) are involved in key signaling events/pathways that regulate cancer
cell proliferation, apoptosis, angiogenesis and metastasis. Deregulated activity of TKs has …

Mechanisms of resistance to imatinib and second-generation tyrosine inhibitors in chronic myeloid leukemia

D Milojkovic, J Apperley - Clinical Cancer Research, 2009 - AACR
Targeted therapy in the form of selective tyrosine kinase inhibitors (TKI) has transformed the
approach to management of chronic myeloid leukemia (CML) and dramatically improved …

[HTML][HTML] Tyrosine kinase inhibitors as reversal agents for ABC transporter mediated drug resistance

N Anreddy, P Gupta, RJ Kathawala, A Patel… - Molecules, 2014 - mdpi.com
Tyrosine kinases (TKs) play an important role in pathways that regulate cancer cell
proliferation, apoptosis, angiogenesis and metastasis. Aberrant activity of TKs has been …

Endogenous gene and protein expression of drug-transporting proteins in cell lines routinely used in drug discovery programs

G Ahlin, C Hilgendorf, J Karlsson, CAK Szigyarto… - Drug metabolism and …, 2009 - ASPET
The aim of this study was to investigate the gene and protein expression profiles of important
drug-transporting proteins in human cell lines commonly used for studies of drug transport …

[HTML][HTML] Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells

F Xu, F Wang, T Yang, Y Sheng, T Zhong… - Cancer cell …, 2014 - Springer
Background Several signal transduction pathways have been reported being involved in the
acquisition of P-glycoprotein (P-gp) mediated multi-drug resistance (MDR) upon exposure to …

[HTML][HTML] Novel angiotensin receptor blocker, azilsartan induces oxidative stress and NFkB-mediated apoptosis in hepatocellular carcinoma cell line HepG2

E Ahmadian, AY Khosroushahi, A Eftekhari… - Biomedicine & …, 2018 - Elsevier
Overexpression of renin angiotensin system (RAS) components and nuclear factor-kappa B
(NF-kB) has a key role in various cancers. Blockade of RAS and NF-kB pathway has been …

[HTML][HTML] Inhibition of NF-κB signaling by quinacrine is cytotoxic to human colon carcinoma cell lines and is synergistic in combination with tumor necrosis factor-related …

TS Jani, J DeVecchio, T Mazumdar, A Agyeman… - Journal of Biological …, 2010 - ASBMB
Colorectal cancer is the third most common malignancy in the United States. Modest
advances with therapeutic approaches that include oxaliplatin (l-OHP) have brought the …

Abnormalities in glucose uptake and metabolism in imatinib-resistant human BCR-ABL–positive cells

DJ Kominsky, J Klawitter, JL Brown, LG Boros… - Clinical Cancer …, 2009 - AACR
The development of imatinib resistance has become a significant therapeutic problem in
which the etiology seems to be multifactorial and poorly understood. As of today, clinical …

[HTML][HTML] Drug resistance mechanisms in non-small cell lung carcinoma

J Wangari-Talbot, E Hopper-Borge - Journal of cancer research …, 2013 - ncbi.nlm.nih.gov
Lung cancer is the most commonly diagnosed cancer in the world.“Driver” and “passenger”
mutations identified in lung cancer indicate that genetics play a major role in the …